Rein Therapeutics, Inc. Proceeds from Issuance of Warrants
Rein Therapeutics, Inc. (RNTX) reported Proceeds from Issuance of Warrants of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-08-14
- Rein Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2025-12-31 was $0.00.
- Rein Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2025-09-30 was $0.00.
- Rein Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2024-12-31 was $0.00.
- Rein Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2024-09-30 was -$195.00K.
- Rein Therapeutics, Inc. proceeds from issuance of warrants for fiscal 2025 was $481.00K, a 93.16% decline from fiscal 2024.
- Rein Therapeutics, Inc. proceeds from issuance of warrants for fiscal 2024 was $7.03M.
- Rein Therapeutics, Inc. proceeds from issuance of warrants for fiscal 2023 was $0.00.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month | Proceeds from Issuance of Warrants 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $481.00K 10-K · filed 2026-03-26 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $481.00K 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | $481.00K 10-Q · filed 2026-08-14 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$195.00K derived: sum of 2 quarters · filed 2026-03-26 | $6.29M derived: sum of 3 quarters · filed 2026-03-26 | $7.03M 10-K · filed 2026-03-26 | |
| 2024-09-30 | -$195.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $6.29M derived: sum of 2 quarters · filed 2025-11-14 | $7.03M 10-Q · filed 2025-11-14 | $7.03M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $6.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $7.22M 10-Q · filed 2025-08-14 | $7.22M derived: sum of 3 quarters · filed 2025-08-14 | $7.22M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $741.00K 10-Q · filed 2024-05-15 | $741.00K derived: sum of 2 quarters · filed 2025-04-07 | $741.00K derived: sum of 3 quarters · filed 2025-04-07 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07 | $0.00 derived: sum of 2 quarters · filed 2025-04-07 | $0.00 10-K · filed 2025-04-07 | $741.00K 10-K · filed 2024-04-15 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |